Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Grant revenue	$ 51,429	$ 67,435
Operating expenses:
Research and development	4,018,659	5,237,424
General and administrative	3,119,216	3,213,198
Total operating expenses	7,137,875	8,450,622
Loss from operations	(7,086,446)	(8,383,187)
Other income:
Interest income	35,079	7,185
Total other income	35,079	7,185
Net loss	$ (7,051,367)	$ (8,376,002)
Net loss per share, basic (in Dollars per share)	$ (0.19)	$ (0.33)
Weighted average common shares outstanding, basic (in Shares)	36,193,085	25,371,781
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Net loss	$ (7,051,367)	$ (8,376,002)
Other comprehensive loss:
Foreign currency translation adjustments	(18,669)	47,234
Comprehensive loss	$ (7,070,036)	$ (8,328,768)